Jci_page_head_homepage_01 Jci_page_head_homepage_02
Brian J. Druker, Nicholas B. Lydon
Published in Volume 105, Issue 1
J Clin Invest. 2000; 105(1):3 doi:10.1172/JCI9083
Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2012 2011 2010 2009 2008 2006 2005 2004 2003 2002 2001 Total
Citations: 6 10 3 1 1 1 3 3 2 5 6 41

Citations to this article in CrossRef (41)

Title and authors Publication Year
Therapeutic inhibition of the Janus kinases
Arian Laurence, Kamran Ghoreschi, Kiyoshi Hirahara, Xiangping Yang, John J. O'Shea
Inflammation and Regeneration 2012
Hurdles in anticancer drug development from a regulatory perspective
Bertil Jonsson, Jonas Bergh
Nat Rev Clin Oncol 2012
Perspectives on personalized cancer care
Garrett M. Dancik, Dan Theodorescu
Urol Oncol Semin Orig Invest 2012
Are breast cancers driven by fusion genes?
Paul AW Edwards, Karen D Howarth
Breast Cancer Res 2012
Treatment options for chronic myeloid leukemia
Maria Florencia Tanaka, Hagop Kantarjian, Jorge Cortes, Maro Ohanian, Elias Jabbour
Expert Opin. Pharmacother. 2012
FMSKinase Inhibitors: Current Status and Future Prospects : FMS KINASE INHIBITORS
Mohammed I. El-Gamal, Hanan S. Anbar, Kyung Ho Yoo, Chang-Hyun Oh
Med. Res. Rev. 2012
Single-Molecule Recognition of Biomolecular Interaction <i>via</i> Kelvin Probe Force Microscopy
Jinsung Park, Jaemoon Yang, Gyudo Lee, Chang Young Lee, Sungsoo Na, Sang Woo Lee, Seungjoo Haam, Yong-Min Huh, Dae Sung Yoon, Kilho Eom
ACS Nano 2011
Current opinions and controversies in chronic myeloid leukaemia :
Bhuvan Kishore, David Marin
Current Opinion in Oncology 2011
Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways
Carine Tang, Lisa Schafranek, Dale B. Watkins, Wendy T. Parker, Sarah Moore, Jodi A. Prime, Deborah L. White, Timothy P. Hughes
Leukemia & Lymphoma 2011
Tyrosine kinase inhibitor therapy for systemic sclerosis: Quo Vadis?
Fabian A. Mendoza, Sergio A. Jiménez
Arthritis Rheum 2011